nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Age at Onset of Heart Failure and Subsequent Risk of Dementia
|
Zheng, Fanfan |
|
|
12 |
5 |
p. 826-835 |
artikel |
2 |
Aging in Heart Failure
|
Goyal, Parag |
|
|
12 |
5 |
p. 795-809 |
artikel |
3 |
Association of Hepatic Triglyceride Content With Cardiac Structure and Function Among Community-Dwelling Adults
|
Saha, Srishti |
|
|
12 |
5 |
p. 958-960 |
artikel |
4 |
Association of Pulmonary Artery Pressures With Mortality in Adults With Reduced Left Ventricular Ejection Fraction
|
Ratwatte, Seshika |
|
|
12 |
5 |
p. 936-945 |
artikel |
5 |
Barriers and Facilitators to Prescribing Guideline-Directed Medical Therapy for Heart Failure in the Indian Health Service
|
Eberly, Lauren A. |
|
|
12 |
5 |
p. 961-963 |
artikel |
6 |
Chronic Kidney Disease Progression in Heart Failure
|
Heerspink, Hiddo J.L. |
|
|
12 |
5 |
p. 860-863 |
artikel |
7 |
Clonal Hematopoiesis
|
Walsh, Kenneth |
|
|
12 |
5 |
p. 915-917 |
artikel |
8 |
Clonal Hematopoiesis Has Prognostic Value in Dilated Cardiomyopathy Independent of Age and Clone Size
|
Sikking, Maurits A. |
|
|
12 |
5 |
p. 905-914 |
artikel |
9 |
Concerning Trends of Rising Heart Failure Mortality Rates
|
Bozkurt, Biykem |
|
|
12 |
5 |
p. 970-972 |
artikel |
10 |
Contemporary American and European Guidelines for Heart Failure Management
|
Ostrominski, John W. |
|
|
12 |
5 |
p. 810-825 |
artikel |
11 |
Dementia Screening
|
Fedson, Savitri |
|
|
12 |
5 |
p. 836-838 |
artikel |
12 |
Elevated Tricuspid Regurgitation Velocity in Left Ventricular Dysfunction
|
Srivastava, Mukta C. |
|
|
12 |
5 |
p. 946-948 |
artikel |
13 |
Expediting Uptake of New and Recommended Therapies
|
Rose, Adam J. |
|
|
12 |
5 |
p. 876-877 |
artikel |
14 |
Factors Impacting Physician Prognostic Accuracy in Heart Failure Patients With Reduced Left Ventricular Ejection Fraction
|
Alba, Ana C. |
|
|
12 |
5 |
p. 878-889 |
artikel |
15 |
Full issue PDF
|
|
|
|
12 |
5 |
p. e1-e178 |
artikel |
16 |
Heart Failure Training for the Internist
|
Gorodeski, Eiran Z. |
|
|
12 |
5 |
p. 954-957 |
artikel |
17 |
Impact of Insurance Status and Region on Angiotensin Receptor–Neprilysin Inhibitor Prescription During Heart Failure Hospitalizations
|
Davogustto, Giovanni |
|
|
12 |
5 |
p. 864-875 |
artikel |
18 |
Incidence, Outcomes, and Opportunity for Left Ventricular Assist Device Weaning for Myocardial Recovery
|
Itagaki, Shinobu |
|
|
12 |
5 |
p. 893-901 |
artikel |
19 |
Predicted Deleterious Variants in Cardiomyopathy Genes Prognosticate Mortality and Composite Outcomes in the UK Biobank
|
Asatryan, Babken |
|
|
12 |
5 |
p. 918-932 |
artikel |
20 |
Prevalence and Prognostic Impact of Drug Use in Patients Hospitalized for Acute Heart Failure
|
Fauvel, Charles |
|
|
12 |
5 |
p. 967-969 |
artikel |
21 |
Recurrent Hospitalizations and Response to Vericiguat in Heart Failure and Reduced Ejection Fraction
|
Mentz, Robert J. |
|
|
12 |
5 |
p. 839-846 |
artikel |
22 |
Reversing Advanced Heart Failure and its Practice? ∗
|
Birks, Emma J. |
|
|
12 |
5 |
p. 902-904 |
artikel |
23 |
Sodium Glucose Co-Transporter 2 Inhibition Following Acute Myocardial Infarction
|
Peikert, Alexander |
|
|
12 |
5 |
p. 949-953 |
artikel |
24 |
Systemic Barriers to Cardiovascular Health in American Indian Communities ∗
|
Deen, Jason F. |
|
|
12 |
5 |
p. 964-966 |
artikel |
25 |
The Quagmire of Prognostication in Heart Failure
|
Taylor, Christy N. |
|
|
12 |
5 |
p. 890-892 |
artikel |
26 |
Toward Proactive “Sequence-First” Risk Prediction for Inherited Cardiomyopathies ∗
|
Jurgens, Sean J. |
|
|
12 |
5 |
p. 933-935 |
artikel |
27 |
Trajectories of Kidney Function in Heart Failure Over a 15-Year Follow-Up
|
Zamora, Elisabet |
|
|
12 |
5 |
p. 849-859 |
artikel |
28 |
Vericiguat and Total Heart Failure Hospitalizations ∗
|
Drazner, Mark H. |
|
|
12 |
5 |
p. 847-848 |
artikel |